Security Snapshot

Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) Institutional Ownership

CUSIP: M2197Q107

13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

210

Shares (Excl. Options)

129,178,607

Price

$18.03

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Ordinary shares, par value of NIS 0.00001 per share
Symbol
CLBT on Nasdaq
Shares outstanding
248,571,184
Price per share
$13.78
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
129,178,607
Total reported value
$2,327,544,159
% of total 13F portfolios
0.02%
Share change
+676,433
Value change
+$10,666,072
Number of holders
210
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • CLBT - Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share is tracked under CUSIP M2197Q107.
  • 210 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 210 to 8 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,327,544,159 to $6,354,532.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 210 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP M2197Q107?
CUSIP M2197Q107 identifies CLBT - Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SUNCORPORATION 43% -2.3% $1,915,539,751 +$63,014,988 106,065,324 +3.4% SUNCORPORATION 31 Dec 2025
TWC Tech Holdings II, LLC 6.1% $294,700,753 14,661,729 Adam H. Clammer 18 Mar 2025
FMR LLC 4.1% -22% $199,496,862 -$13,992,153 9,925,217 -6.6% FMR LLC 31 Mar 2025

As of 31 Dec 2025, 210 institutional investors reported holding 129,178,607 shares of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT). This represents 52% of the company’s total 248,571,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) together control 38% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
True Wind Capital Management, L.P. 5.6% 13,861,007 0% 96% $249,913,956
FMR LLC 3.8% 9,347,182 +54% 0.01% $168,529,699
T. Rowe Price Investment Management, Inc. 3.4% 8,514,894 -15% 0.1% $153,524,000
Voss Capital, LP 3.2% 8,050,000 +19% 7.7% $145,141,500
Pertento Partners LLP 2.4% 5,959,324 +28% 12% $107,446,612
Invesco Ltd. 2.3% 5,603,237 +0.77% 0.02% $101,026,363
BlackRock, Inc. 1.7% 4,328,913 +16% 0% $78,050,301
Clal Insurance Enterprises Holdings Ltd 1.4% 3,473,014 -11% 0.4% $62,618,000
Granahan Investment Management, LLC 1.2% 3,057,018 +16% 2.4% $55,118,035
Phoenix Financial Ltd. 1% 2,510,774 +0.15% 0.49% $45,267,596
RENAISSANCE TECHNOLOGIES LLC 1% 2,494,939 -14% 0.07% $44,983,750
Nine Ten Capital Management LLC 1% 2,479,727 0% 14% $44,709,000
Capital Research Global Investors 0.97% 2,405,172 -0.85% 0.01% $43,365,251
COOPER CREEK PARTNERS MANAGEMENT LLC 0.96% 2,395,973 -21% 2% $43,199,000
MORGAN STANLEY 0.96% 2,390,114 -17% 0% $43,093,756
Nuveen, LLC 0.92% 2,279,640 +6% 0.01% $41,101,910
Capital International Investors 0.92% 2,278,040 0.01% $41,073,061
ASHFORD CAPITAL MANAGEMENT INC 0.67% 1,670,845 -1.7% 3.4% $30,125,335
PRINCIPAL FINANCIAL GROUP INC 0.65% 1,610,832 -2.8% 0.01% $29,043,301
Greenhaven Road Investment Management, L.P. 0.64% 1,599,937 -3.2% 12% $28,846,864
Handelsbanken Fonder AB 0.61% 1,510,000 -48% 0.08% $27,225,000
AXON ENTERPRISE, INC. 0.61% 1,509,341 -59% 100% $27,213,418
MEITAV INVESTMENT HOUSE LTD 0.59% 1,454,846 0% 0.32% $26,230,873
RAYMOND JAMES FINANCIAL INC 0.58% 1,453,096 -2.9% 0.01% $26,144,060
Artisan Partners Limited Partnership 0.58% 1,434,888 0.04% $25,871,031

Institutional Holders of Cellebrite DI Ltd. - Ordinary shares, par value of NIS 0.00001 per share (CLBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 454,896 $6,354,532 -$1,805,062 $13.78 8
2025 Q4 129,178,607 $2,327,544,159 +$10,666,072 $18.03 210
2025 Q3 129,479,868 $2,399,228,901 +$236,282,955 $18.53 196
2025 Q2 118,023,067 $1,888,023,265 +$96,376,127 $16.00 207
2025 Q1 111,091,356 $2,158,060,728 +$17,336,152 $19.43 196
2024 Q4 109,611,642 $2,414,743,153 +$172,628,937 $22.03 190
2024 Q3 92,027,552 $1,549,738,036 +$162,565,361 $16.84 162
2024 Q2 82,827,477 $989,795,174 +$84,273,008 $11.95 146
2024 Q1 75,864,626 $836,285,496 +$117,532,707 $11.08 138
2023 Q4 86,517,854 $748,725,177 +$75,873,899 $8.66 116
2023 Q3 53,304,550 $402,692,089 +$106,109,469 $7.65 93
2023 Q2 38,873,021 $279,822,194 +$12,002,094 $7.20 75
2023 Q1 37,362,412 $227,499,632 +$5,419,519 $6.09 57
2022 Q4 40,117,660 $174,910,523 -$3,630,060 $4.36 51
2022 Q3 41,084,252 $161,537,648 +$10,182,285 $3.92 43
2022 Q2 38,483,927 $196,125,190 -$3,326,950 $5.10 45
2022 Q1 38,618,479 $247,169,160 +$8,435,170 $6.40 49
2021 Q4 36,614,332 $293,619,620 +$8,905,659 $8.02 48
2021 Q3 21,734,465 $200,833,000 +$200,767,000 $9.26 25

Sponsored